The target audience is healthcare professionals, specifically oncologists who treat advanced prostate cancer.

As unfortunately many patients’ cancer will progress, it’s likely they will receive a number of treatments. This piece raises awareness that it is not only which treatments these patients receive that is important, but also the sequence.